🏥 Health 1d ago

View Channel →

0 0 Save Read Full Article Source ↗ 👁 0 💬 0

(MedPage Today) -- The FDA is requiring manufacturers of all GLP-1 drugs to update their prescribing information to include a warning about the potential risk of non-arteritic anterior ischemic optic neuropathy (NAION), a rare but potentially blinding...

Sign in to join the discussion

STAT+: Ionis Pharmaceuticals shares plummet after slow rollout of biotech’s triglyceride-lowering drug

STAT · 1d ago

Common Antibiotic Tied to Pregnancy Loss Risk

MedPageToday.com - medical news for physicians · 1d ago

Smartwatch Detection of Reduced LVEF? Not So Fast, Study Says.

MedPageToday.com - medical news for physicians · 1d ago

Police Investigate After 25 Half-Marathon Runners Seek Medical Care

MedPageToday.com - medical news for physicians · 1d ago

📰

DAISY Award spotlight: ‘She turned the most painful day of our lives into ones filled with love, honor, and peace for our baby boy.’

Vanderbilt Health News · 1d ago

Early Response to MASH Drug Linked to Resolution, Fibrosis Improvement

MedPageToday.com - medical news for physicians · 1d ago